Medtide Inc. (SEHK: 3880)
Health Care · Life Sciences Tools & Services · CN
HK$20.76
-1.98% today · -32.2% 1Y
Medtide Inc. (SEHK: 3880) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $375.12M and employs 566 people.
Over the last twelve months the share price has lost 32.2%, trading between 17.64 and 31.98.
Tweenvest scores Medtide Inc. across four factors: quality 82/100, value 73/100. Its strongest factor is quality.
3880 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $375.12M
- Revenue (TTM)
- $81.09M
- P/E
- 15.10
- EPS
- 1.19
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$31.98
- 52-week low
- HK$17.64
- Avg volume (3M)
- —
- Shares outstanding
- 141.80M
- Employees
- 566
- Next earnings
- —
About Medtide Inc.
Medtide Inc. operates as a contract research, development, and manufacturing organization (CRDMO), providing comprehensive services across the entire pharmaceutical lifecycle, from initial drug discovery and preclinical investigation through to clinical development and commercial-scale production. The company specializes in the synthesis of novel peptide chemical entities for discovery purposes, along with the development of peptide-based chemistry, manufacturing, and control (CMC) processes, and their subsequent commercial manufacturing. A core area of its developmental focus is on glucagon-like peptide-1 (GLP-1) molecules, which it designs for both oral and/or injectable administration. Medtide leverages a suite of proprietary research and development platforms, including OmniPeptSynth, PeptiConjuX, PeptiNuclide LinkTech, GreenSynth Innovations, and Impurity Screening. Its client base spans multiple regions globally, including China, the United States, Japan, Europe, South Korea, and Australia. Established in 2020 as Taide Pharmaceutical (Zhejiang) Co., Ltd, the company rebranded to Medtide Inc. in February 2023 and maintains its headquarters in Hangzhou, China.
- ISIN
- CNE100006S86
- Founded
- 2020
- Listed since
- Jun 30, 2025
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alpha Teknova, Inc.NasdaqGM: TKNO | $474.60M | $8.53 | -3.51% |
| Viva Biotech HoldingsSEHK: 1873 | $408.85M | HK$1.55 | +1.31% |
| Zhejiang Tailin BioEngineering Co.,LtdSZSE: 300813 | $403.22M | CN¥22.51 | -1.40% |
| Shin Nippon Biomedical Laboratories, Ltd.TSE: 2395 | $379.40M | ¥1,443.00 | +11.60% |
| Quantum-Si incorporatedNasdaqGM: QSI | $334.89M | $1.40 | -8.82% |
| Zhejiang Taimei Medical Technology Co., Ltd.SEHK: 2576 | $320.71M | HK$4.50 | -5.26% |
| Improve Medical Instruments Co., Ltd.SZSE: 300030 | $318.97M | CN¥6.91 | -0.14% |
| Locus Cell Co., Ltd.TPEX: 6891 | $307.05M | NT$48.95 | +14.50% |
Figures last refreshed Oct 11, 2026.